Context Therapeutics Inc. (NASDAQ:CNTX) Receives $6.17 Average Target Price from Brokerages
Shares of Context Therapeutics Inc. (NASDAQ:CNTX – Get Free Report) have received an average rating of “Buy” from the seven ratings firms that are presently covering the company, Marketbeat.com reports. Six equities research analysts have rated the stock with a buy rating and one has given a strong buy rating to the company. The average […]
Shares of Context Therapeutics Inc. (NASDAQ:CNTX – Get Free Report) have received an average rating of “Buy” from the seven ratings firms that are presently covering the company, Marketbeat.com reports. Six equities research analysts have rated the stock with a buy rating and one has given a strong buy rating to the company. The average […]
